S
27.66
+0.55%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$1.18bn
FY2016FY2025
Net income
−$405.4m
FY2016FY2025
Free cash flow
$80.8m
FY2016FY2025
Shareholders' equity
$427.5m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.18bn | $901.5m | $2.98bn | $3.11bn | $1.96bn | $1.46bn | $1.43bn | $937.2m | $607.0m | $480.0m |
| Gross profit | $181.6m | −$877.2m | $703.8m | $844.6m | $629.3m | $461.4m | $479.3m | $319.2m | $214.8m | $161.9m |
| Research and development | $221.3m | $277.2m | $321.5m | $289.8m | $219.6m | $163.1m | $121.4m | $82.2m | $55.0m | $40.6m |
| Operating income | −$310.9m | −$1.71bn | $40.2m | $166.1m | $207.1m | $142.6m | $189.9m | $139.4m | $91.1m | $67.1m |
| Net income | −$405.4m | −$1.81bn | $34.3m | $93.8m | $169.2m | $140.3m | $146.5m | $128.8m | $84.2m | $50.8m |
| Diluted earnings per share | -6.78 | -31.42 | 0.60 | 1.60 | 3.02 | 2.62 | 2.88 | 2.70 | 1.80 | 1.16 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.18bn | $2.63bn | $4.59bn | $4.27bn | $2.90bn | $2.44bn | $1.49bn | $964.5m | $641.3m | $424.7m |
| Cash and short-term investments | $577.9m | $585.9m | $860.0m | $1.02bn | $697.8m | $1.03bn | $320.8m | $316.3m | $240.4m | $180.0m |
| Total liabilities | $1.75bn | $1.97bn | $2.18bn | $2.09bn | $1.59bn | $1.35bn | $683.0m | $393.7m | $243.8m | $136.0m |
| Debt | $331.6m | $719.0m | $673.0m | $673.1m | $662.0m | $618.1m | $18.5m | $20.1m | $1.8m | $2.1m |
| Shareholders' equity | $427.5m | $658.3m | $2.41bn | $2.18bn | $1.31bn | $1.09bn | $811.7m | $562.4m | $397.5m | $288.8m |
| Shares outstanding | 60m | 57m | 57m | 59m | 56m | 53m | 51m | 48m | 47m | 44m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $104.3m | −$313.3m | −$180.1m | $31.3m | $214.1m | $222.7m | $259.0m | $189.1m | $136.7m | $49.1m |
| Capital spending | −$23.5m | −$108.2m | −$170.5m | −$169.3m | −$149.3m | −$126.8m | −$72.6m | −$38.6m | −$21.4m | −$11.6m |
| Free cash flow | $80.8m | −$421.5m | −$350.6m | −$138.1m | $64.9m | $95.9m | $186.4m | $150.5m | $115.3m | $37.5m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $346.2m | $310.5m | $335.4m | $340.2m | $289.4m | $219.5m | $170.7m | $260.9m |
| Gross profit | $95.2m | $68.2m | $74.4m | $57.6m | $32.1m | $17.5m | −$137.7m | −$702.3m |
| Operating income | −$16.0m | −$55.0m | −$31.8m | −$35.2m | −$69.2m | −$102.7m | −$289.1m | −$1.09bn |
| Net income | −$30.8m | −$57.4m | −$132.1m | −$50.1m | −$124.7m | −$98.5m | −$312.9m | −$1.21bn |
| Diluted earnings per share | -0.50 | -0.93 | -2.21 | -0.84 | -2.09 | -1.65 | -5.44 | -20.97 |
| Cash from operations | $11.0m | $24.0m | $52.0m | $25.0m | −$7.0m | $33.0m | $12.0m | −$63.0m |
| Capital spending | −$8.0m | −$3.0m | −$9.0m | −$2.0m | −$1.0m | −$10.0m | −$12.0m | −$47.0m |
| Free cash flow | $3.0m | $21.0m | $43.0m | $23.0m | −$8.0m | $23.0m | $0 | −$110.0m |
| Total assets | $2.30bn | $2.26bn | $2.18bn | $2.23bn | $2.49bn | $2.53bn | $2.63bn | $2.82bn |
| Cash and short-term investments | $546.9m | $582.6m | $493.2m | $498.6m | $758.0m | $651.6m | $585.9m | $678.8m |
| Debt | $332.3m | $346.7m | $331.6m | $344.9m | $686.7m | $686.9m | $688.2m | $688.0m |
| Shareholders' equity | $412.1m | $410.7m | $427.5m | $479.8m | $513.2m | $594.2m | $658.3m | $956.4m |
Financial ratios
Data as of 29 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 15.3% | -97.3% | 23.6% | 27.2% | 32.0% | 31.6% |
| Operating margin | -26.2% | -188.6% | 2.9% | 5.8% | 9.7% | 11.4% |
| Net margin | -34.2% | -200.4% | 1.2% | 3.0% | 8.6% | 9.6% |
| Return on equity | -94.8% | -274.4% | 1.4% | 4.3% | 12.9% | 12.9% |
| Return on assets | -18.6% | -68.7% | 0.7% | 2.2% | 5.8% | 5.8% |
| Free cash flow yield | 7.2% | -12.1% | -0.6% | 11.6% | 22.0% | 22.2% |
| Revenue growth | 31.4% | -69.7% | -4.3% | 58.4% | 34.6% | 2.4% |
| Earnings growth | -77.6% | -5361.9% | -63.4% | -44.6% | 20.6% | -4.2% |
| Current ratio | 2.17x | 1.95x | 3.70x | 3.26x | 3.26x | 3.94x |
| Debt to equity | 0.78x | 1.05x | 0.27x | 0.30x | 0.48x | 0.55x |
| Equity ratio | 19.6% | 25.0% | 52.6% | 51.0% | 45.2% | 44.6% |
| Interest coverage | -3.84x | -91.16x | 5.54x | 16.81x | 17.86x | 15.80x |
| R&D as a share of sales | 18.7% | 30.8% | 10.8% | 9.3% | 11.2% | 11.2% |
| Buybacks as a share of market value | -4.1% | -1.0% | 3.1% | -4.9% | -4.7% | -5.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -27.5% | -4.1% | 13.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | -33.3% | 10.4% | 16.8% | 20.8% |
| Operating margin | -96.8% | -22.2% | -12.6% | -6.2% |
| Net margin | -106.0% | -25.5% | -15.3% | -8.7% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -4.3 | -0.4 | 155.2 | 177.4 | 92.9 | 121.7 | 33.1 | 13.0 | 20.9 | 10.7 |
| Price to sales | 1.5 | 0.9 | 1.8 | 5.3 | 8.0 | 11.7 | 3.4 | 1.8 | 2.9 | 1.1 |
Market value over time
30 Nov 2016 to 28 Oct 2026, in USD
$580.7m$1.81bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Return | 106% | -86% | -67% | 20% | -19% | 235% | 170% | -8% | 183% | -52% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.